None of the tumor cells in dogs with T cell neoplasms were labeled with the anti-CD80 antibody (Figure 4, Table 6, Supplementary Table S4); however, the cells were CD11b+ (2/22, 9%) or CD11c+ (6/19, 32%) in low numbers of dogs. Here, ITGAX is linked to neoplasm.